Refinement and feasibility testing of a manual micro-method for protamine titration

International Journal of Laboratory Hematology

Volumn 31, Issue 4, 2009, Pages 457-461

  Newall, F ^a,b   Johnston, L ^a,b   Ignjatovic, V ^a,b   Summerhayes, R ^a,b   Monagle, P ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Laboratory monitoring; Protamine titration; Unfractionated heparin therapy

Indexed keywords

HEPARIN; PROTAMINE SULFATE;

ANGIOCARDIOGRAPHY; ARTICLE; BOLUS INJECTION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DRUG DOSE TITRATION; FEASIBILITY STUDY; HUMAN; IN VIVO STUDY; INFANT; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TITRIMETRY;

CHILD; CHILD, PRESCHOOL; FACTOR XA; HEPARIN; HUMANS; INFANT; PROTAMINES; TITRIMETRY;

EID: 67651092016     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01055.x     Document Type: Article

References (17)

1. Andrew M., Monagle P. Brooker L. (2000) Thromboembolic Complications During Infancy and Childhood. BC. Decker, Hamilton.
2. Brill-Edwards P., Ginsberg J., Johnston M. Hirsh J. (1993) Establishing a therapeutic range for heparin therapy. Annals of Internal Medicine 119, 104 109.
3. Carr J. Silverman N. (1999) The heparin-protamine interaction: a review. The Journal of Cardiovascular Surgery 40, 659 666.
4. Chan A., Black L., Ing C., Brandão L. Williams S. (2008) Utility of aPTT in monitoring unfractionated heparin in children. Thrombosis Research 122, 135 136.
5. Hirsh J. Raschke R. (2004) Heparin and low-molecular-weight heparin. Chest 126, 188S 203S.
6. Hull R. (1995) Anticoagulant treatment. International Angiology 14, 32 44.
7. Hull R., Raskob G., Hirsh J., Jay R., Leclerc J., Geerts W., Rosenbloom D., Sackett D., Anderson C., Harrison L. Gent M. (1986) Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. The New England Journal of Medicine 315, 1109 1114.
8. Hull R., Raskob G., Rosenbloom D., Panju A., Brill-Edwards P. Ginsberg J. (1990) Heparin for 5 days as compared to 10 days in the initial treatment of proximal venous thrombosis. New England Journal of Medicine 322, 1260 1264.
9. Ignjatovic V., Furmedge J., Newall F., Chan A., Berry L., Fong C., Cheng K. Monagle P. (2006a) Age-related differences in heparin response. Thrombosis Research 118, 741 745.
10. Ignjatovic V., Summerhayes R., Than J., Gan A. Monagle P. (2006b) Therapeutic range for unfractionated heparin therapy: age-related differences in response in children. Journal of Thrombosis and Haemostasis 4, 2280 2282.
11. Ignjatovic V., Summerhayes R., Gan A., Than J., Chan A., Cochrane A., Bennet M., Shann F., Lane G., Ross-Smith M. Monagle P. (2007) Monitoring unfractionated heparin (UFH) therapy: which anti factor Xa assay is appropriate? Thrombosis Research 120, 347 351.
12. Kitchen S. (2000) Problems in laboratory monitoring of heparin dosage. British Journal of Haematology 111, 397 406.
13. Laffan M. Manning R. (2001) Laboratory control of anticoagulant, thrombolytic and anti-platelet therapy. In : Dacie and Lewis: Practical Haematology (eds S. Lewis, B. Bain I. Bates pp. 465 479. Churchill Livingstone, London.
14. Monagle P., Barnes C., Ignjatovic V., Furmedge J., Newall F., Chan A., DeRosa L., Hamilton S., Ragg P., Robinson S., Auldist A., Crock C. Rowlands S. (2006) Developmental haemostasis: impact for clinical haemostasis laboratories. Thrombosis and Haemostasis 95, 362 372.
15. Refn I. Vestergaard L. (1954) The Titration of Heparin with Protamine. Scandinavian Journal of Clinical and Laboratory Investigation 6, 284 287.
16. Teng C. Yang V. (1989) A facile colorimetric protamine titration method. The Journal of Laboratory and Clinical Medicine 113, 498 504.
17. Turpie A., Robinson J., Doyle D., Mulji A., Mishkel G. Sealey B. (1989) Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. New England Journal of Medicine 320, 352 357.